Clinical Trials Directory

Trials / Terminated

TerminatedNCT03638947

Reducing Perioperative S. Aureus Transmission

Reducing Perioperative S. Aureus Transmission Via Use of an Evidence-Based, Multimodal Program Driven by an Innovative Software Platform (OR Path Trac)

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
236 (actual)
Sponsor
Randy Loftus · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to prevent the spread of S. aureus, a dangerous bacterium, within the operating room and between patients undergoing surgery.

Detailed description

The purpose of this study is to prevent the spread of S. aureus, a dangerous bacterium, within the operating room and between patients undergoing surgery. The investigators will combine several approaches in a "bundle" of activities to achieve this goal. The bundle will include removal of bacterial pathogens from patient skin sites before surgery, from provider hands before, during, and after surgery, from environmental surfaces before and after terminal cleaning, and from the injection ports of patient intravenous catheters. The investigators will use a new surveillance system to evaluate how well the bundle, and each component of the bundle, is working. Surveillance will identify S. aureus transmission events, and movement of S. aureus between reservoirs before, during, and after surgery (perioperative). Surveillance will map transmission events to identify actionable steps to improve the bundle. An infection control perioperative team will act on the surveillance reports to proactively address the action items, and to measure the effect of their efforts for the treatment group. The investigators will compare perioperative S. aureus transmission events for patients receiving the bundle to perioperative S. aureus transmission events for patients receiving usual care.

Conditions

Interventions

TypeNameDescription
DEVICESwab and decolonization using povidone-iodine cleansingPatient in this group will receive improved environmental cleaning and undergo surveillance using swabs and decolonization cleansing.

Timeline

Start date
2018-09-20
Primary completion
2021-01-01
Completion
2021-01-01
First posted
2018-08-20
Last updated
2022-07-01
Results posted
2022-07-01

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03638947. Inclusion in this directory is not an endorsement.